Literature DB >> 9477544

Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas.

F P Pinheiro, S J Corber.   

Abstract

About two-thirds of the world's population live in areas infested with dengue vectors, mainly Aedes aegypti. All four dengue viruses are circulating, sometimes simultaneously, in most of these areas. It is estimated that up to 80 million persons become infected annually although marked underreporting results in the notification of much smaller figures. Currently dengue is endemic in all continents except Europe and epidemic dengue haemorrhagic fever (DHF) occurs in Asia, the Americas and some Pacific islands. The incidence of DHF is much greater in the Asian countries than in other regions. In Asian countries the disease continues to affect children predominantly although a marked increase in the number of DHF cases in people over 15 years old has been observed in the Philippines and Malaysia during recent years. In the 1990's DHF has continued to show a higher incidence in South-East Asia, particularly in Viet Nam and Thailand which together account for more than two-thirds of the DHF cases reported in Asia. However, an increase in the number of reported cases has been noted in the Philippines, Lao People's Democratic Republic, Cambodia, Myanmar, Malaysia, India, Singapore and Sri Lanka during the period 1991-1995 as compared to the preceding 5-year period. In the Americas, the emergence of epidemic DHF occurred in 1981 almost 30 years after its appearance in Asia, and its incidence is showing a marked upward trend. In 1981 Cuba reported the first major outbreak of DHF in the Americas, during which a total of 344,203 cases of dengue were notified, including 10,312 severe cases and 158 deaths. The DHF Cuban epidemic was associated with a strain of dengue-2 virus and it occurred four years after dengue-1 had been introduced in the island causing epidemics of dengue fever. Prior to this event suspected cases of DHF or fatal dengue cases had been reported by five countries but only a few of them fulfilled the WHO criteria for diagnosis of DHF. The outbreak in Cuba is the most important event in the history of dengue in the Americas. Subsequently to it, in every year except 1983, confirmed or suspected cases of DHF have been reported in the Region. The second major outbreak in the Americas occurred in Venezuela in 1989 and since then this country has suffered epidemics of DHF every year. Between 1981 and 1996 a total of 42,246 cases of DHF and 582 deaths were reported by 25 countries in the Americas, 53% of which originated from Venezuela and 24% from Cuba. Colombia, Nicaragua and Mexico have each reported over 1,000 cases during the period 1992-1996. About 74% of the Colombian cases and 97% of the Mexican cases were reported during 1995-1996. A main cause of the emergence of DHF in the Americas was the failure of the hemispheric campaign to eradicate Aedes aegypti. Following a successful period that resulted in the elimination of the mosquito from 18 countries by 1962, the programme began to decline and as a result there was a progressive dissemination of the vector so that by 1997 with the exception of Canada, Chile and Bermuda, all countries in the Americas are infested. Other factors contributing to the emergence/re-emergence of dengue/DHF include the rapid growth and urbanization of populations in Latin America and the Caribbean, and increased travel of persons which facilitates dissemination of dengue viruses. Presently, all four dengue serotypes are circulating in the Americas, thus increasing the risk for DHF in this region.

Entities:  

Mesh:

Year:  1997        PMID: 9477544

Source DB:  PubMed          Journal:  World Health Stat Q        ISSN: 0379-8070


  79 in total

1.  Educational campaign versus malathion spraying for the control of Aedes aegypti in Colima, Mexico.

Authors:  F Espinoza-Gómez; C Moises Hernández-Suárez; R Coll-Cárdenas
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

2.  B-cell responses during primary and secondary dengue virus infections in humans.

Authors:  Anuja Mathew; Kim West; Siripen Kalayanarooj; Robert V Gibbons; Anon Srikiatkhachorn; Sharone Green; Daniel Libraty; Smita Jaiswal; Alan L Rothman
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

Review 3.  Dengue: defining protective versus pathologic immunity.

Authors:  Alan L Rothman
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

4.  Total economic cost and burden of dengue in Nicaragua: 1996-2010.

Authors:  Zachary S Wettstein; Michael Fleming; Aileen Y Chang; David J Copenhaver; Angela R Wateska; Sarah M Bartsch; Bruce Y Lee; Rajan P Kulkarni
Journal:  Am J Trop Med Hyg       Date:  2012-08-13       Impact factor: 2.345

5.  The epidemiology of dengue in the americas over the last three decades: a worrisome reality.

Authors:  José Luis San Martín; Olivia Brathwaite; Betzana Zambrano; José Orlando Solórzano; Alain Bouckenooghe; Gustavo H Dayan; María G Guzmán
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

6.  Differences in Mortality and Clinical Manifestations of Dengue Hemorrhagic Fever in Taiwan in Different Years: A Comparison for Cases in 2014 and 2015 Epidemics.

Authors:  Ko Chang; Chung-Hao Huang; Ing-Kit Lee; Po-Liang Lu; Chun-Yu Lin; Tun-Chieh Chen; Ping-Chang Lai; Hsiao-Cheng Hsieh; Hsin-Liang Yu; Chih-Hsing Hung; Meng-Chieh Wu; Yi-Ying Chin; Chun-Chi Huang; Deng-Chyang Wu; Yen-Hsu Chen
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

7.  Comparing dengue and chikungunya emergence and endemic transmission in A. aegypti and A. albopictus.

Authors:  Carrie A Manore; Kyle S Hickmann; Sen Xu; Helen J Wearing; James M Hyman
Journal:  J Theor Biol       Date:  2014-05-04       Impact factor: 2.691

8.  Impact of renal failure on the outcome of dengue viral infection.

Authors:  Mei-Chuan Kuo; Po-Liang Lu; Jer-Ming Chang; Ming-Yen Lin; Jih-Jin Tsai; Yen-Hsu Chen; Ko Chang; Hung-Chun Chen; Shang-Jyh Hwang
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 8.237

Review 9.  Plasma leakage in dengue haemorrhagic fever.

Authors:  Anon Srikiatkhachorn
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

Review 10.  Dengue haemorrhagic fever or dengue shock syndrome in children.

Authors:  Marissa M Alejandria
Journal:  BMJ Clin Evid       Date:  2009-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.